MAEL and cancer: Among the five cancer types with the highest MAEL expression, TGCT had equivalent expression levels of MAEL-206 and MAEL-202, while the MAEL expression in the other four cancer types was dominated by MAEL-206 (>90%, Figure 3B), indicating the potential role of MAEL-206 in brain and kidney tumors.